Chemoinformaics analysis of 2,6-Dimethoxy-4-vinylphenol
| Molecular Weight | 180.203 | nRot | 3 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 7 |
| Exact Molecular Weight | 180.079 | nRing | 1 |
| Solubility: LogS | -2.402 | nHRing | 0 |
| Solubility: LogP | 2.124 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 27.1075 |
| nHD | 1 | BPOL | 15.5105 |
| QED | 0.773 |
| Synth | 2.038 |
| Natural Product Likeliness | 0.923 |
| NR-PPAR-gamma | 0.761 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.252 |
| HIA | 0.006 |
| CACO-2 | -4.531 |
| MDCK | 0.0000182 |
| BBB | 0.56 |
| PPB | 0.906643 |
| VDSS | 0.688 |
| FU | 0.0945115 |
| CYP1A2-inh | 0.886 |
| CYP1A2-sub | 0.899 |
| CYP2c19-inh | 0.047 |
| CYP2c19-sub | 0.842 |
| CYP2c9-inh | 0.06 |
| CYP2c9-sub | 0.786 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.887 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.417 |
| CL | 11.837 |
| T12 | 0.894 |
| hERG | 0.032 |
| Ames | 0.01 |
| ROA | 0.316 |
| SkinSen | 0.862 |
| Carcinogencity | 0.301 |
| EI | 0.977 |
| Respiratory | 0.591 |
| NR-Aromatase | 0.654 |
| Antiviral | No |
| Prediction | 0.869359 |